Cannabis Law Report

JUNE 19, 2022

Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

Canna Law Blog

NOVEMBER 27, 2021

Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer.

Therapy 88

Therapy Clinical Trials DEA Microdosing 88

Cannabis Law Report

NOVEMBER 24, 2019

Dr. Johnson recently spoke about microdosing and its affects on creativity. Dr. Griffiths and Dr. Johnson will be speaking at Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks conference in Washington DC. Participate in Our Studies. ANOREXIA NERVOSA. ALZHEIMER’S DISEASE.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

Cannabis Law Report

JUNE 4, 2021

Legislative initiatives (introduction and support of changes of laws). Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Mr Psychedelic Law & Iter Investments.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51